Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020
- PMID: 32271701
- PMCID: PMC7323566
- DOI: 10.3201/eid2607.200275
Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020
Abstract
We report a case of Argentine hemorrhagic fever diagnosed in a woman in Belgium who traveled from a disease-endemic area. Patient management included supportive care and combination therapy with ribavirin and favipiravir. Of 137 potential contacts, including friends, relatives, and healthcare and laboratory workers, none showed development of clinical symptoms of this disease.
Keywords: Argentine hemorrhagic fever; Belgium; JUNV; Junin virus; New World arenaviruses; antiviral drugs; clinical management; containment; favipiravir; public health; ribavirin; travel; viruses.
Figures
References
-
- Blumberg L, Enria D, Bausch DG. Viral haemorrhagic fevers. In: Farrar J, Hotez P, Junghanss T, Kang G, Lalloo D, White N, editors. Manson’s tropical infectious diseases. New York: Elsevier; 2014. p. 171–94.
-
- Romanowski V, Pidre M, Ferrelli ML, Bender C, Gomez R. Argentine hemorrhagic fever. In: Singh SK, Ruzek D, editors. Viral hemorrhagic fevers. Boca Raton (FL): CRC Press; 2013. p. 317–38.
-
- SAVE. Argentine Society of Virology and Argentine Association of Microbiology. Argentine Hemorrhagic Fever. Position paper, 2019. [in Spanish] [cited 2020 Jan 25]. https://save.org.ar/noticias-de-interes/posicion-sobre-fha
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
